| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $442.7M | +7.8% |
| R&D Expense | $116.1M | +162.3% |
| SG&A Expense | $158.3M | +36.5% |
| Operating Income | -$945.4M | -477.7% |
| Interest Expense | $21.6M | +184.7% |
| Pre-tax Income | -$948.1M | -475.6% |
| Income Tax | $83.5M | +7.9% |
| Net Income | -$1.00B | -672.5% |
| EPS (Basic) | -$6.45 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $92.2M | -86.0% |
| Accounts Receivable | $129.1M | +11.8% |
| Current Assets | $233.3M | -70.1% |
| Total Assets | $471.1M | -57.2% |
| Current Liabilities | $276.1M | +981.7% |
| Stockholders' Equity | -$346.3M | -153.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $183.4M | -33.0% |
| Capital Expenditures | $273K | +100.7% |
| Investing Cash Flow | -$1.03B | — |
| Financing Cash Flow | $277.2M | +216.7% |
| Free Cash Flow | $183.2M | -33.1% |
| -670.8% |
| EPS (Diluted) | -$6.45 | -771.9% |